Kabra Drugs informs about standalone financial results

15 Nov 2016 Evaluate

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

32.07 1.52 (4.98%)
09-Mar-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.95
Dr. Reddys Lab 1280.35
Cipla 1311.95
Zydus Lifesciences 890.05
Lupin 2297.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×